Assembly Biosciences, Inc. (ASMB) vs Atea Pharmaceuticals, Inc. (AVIR)
A side-by-side comparison of Assembly Biosciences, Inc. and Atea Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$22.39HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
AVIR
Atea Pharmaceuticals, Inc.
$5.15HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ASMB vs AVIR
growth of $100 · dividends reinvested · last 6yASMB -87.1% (-29.0%/yr)AVIR -83.1% (-25.6%/yr)AVIR compounded faster over this window
ASMB AVIR
ASMB vs AVIR: by the numbers
- •ASMB is the larger company ($444M vs $412M market cap).
Metrics side by side
Valuation
| Metric | ASMB | AVIR |
|---|---|---|
| P/E ratio | 40.70 | N/A |
| P/S ratio | 5.93 | N/A |
| P/B ratio | 1.45 | 2.02 |
Profitability
| Metric | ASMB | AVIR |
|---|---|---|
| Gross margin | 99.82% | 0.00% |
| Operating margin | -11.75% | 0.00% |
| Net margin | -0.06% | 0.00% |
| ROE | -0.01% | -80.96% |
| ROIC | -2.86% | -89.93% |
Growth (annualized)
| Metric | ASMB | AVIR |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | N/A |
| Total return CAGR (5Y) | -10.66% | -34.44% |
Frequently asked
- How have ASMB and AVIR total returns compared?
- Over the past 5 years, ASMB delivered -10.66% and AVIR delivered -34.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.